loadpatents
name:-0.010581970214844
name:-0.0056378841400146
name:-0.001622200012207
RADVANYI; Francois Patent Filings

RADVANYI; Francois

Patent Applications and Registrations

Patent applications and USPTO patent grants for RADVANYI; Francois.The latest application filed is for "prediction of recurrence for bladder cancer by a protein signature in tissue samples".

Company Profile
1.5.11
  • RADVANYI; Francois - Paris FR
  • RADVANYI; FRANCOIS - FONTENAY-AUX-ROSES FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Prediction Of Recurrence For Bladder Cancer By A Protein Signature In Tissue Samples
App 20210123914 - SCHRODER; Christoph ;   et al.
2021-04-29
Prediction of recurrence for bladder cancer by a protein signature in tissue samples
Grant 10,809,261 - Schroder , et al. October 20, 2
2020-10-20
Bladder Cancer Biomarker Proteins
App 20180372754 - GARIN; Jerome ;   et al.
2018-12-27
Anti-tyro3 Antibodies And Uses Thereof
App 20180105596 - DUONG; VANESSA ;   et al.
2018-04-19
Prediction Of Recurrence For Bladder Cancer By A Protein Signature In Tissue Samples
App 20170336414 - SCHRODER; Christoph ;   et al.
2017-11-23
Prediction of recurrence for bladder cancer by a protein signature in tissue samples
Grant 9,678,075 - Schroder , et al. June 13, 2
2017-06-13
Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer
Grant 9,233,144 - Bernard-Pierrot , et al. January 12, 2
2016-01-12
Prediction Of Recurrence For Bladder Cancer By A Protein Signature In Tissue Samples
App 20140193927 - Schroder; Christoph ;   et al.
2014-07-10
Cdkn2a As A Prognostic Marker In Bladder Cancer
App 20130059303 - RADVANYI; FRANCOIS
2013-03-07
Method For Predicting The Sensitivity Of A Tumor To An Epigenetic Treatment
App 20120282167 - Vallot; Celine ;   et al.
2012-11-08
Tyrosine Kinase Receptor Tyro3 As A Therapeutic Target In The Treatment Of Cancer
App 20120034167 - Bernard-Pierrot; Isabelle ;   et al.
2012-02-09
P38Alpha as a Therapeutic Target in Bladder Carcinoma
App 20100166737 - Bernard-Pierrot; Isabelle ;   et al.
2010-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed